GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tilray Brands Inc (NAS:TLRY) » Definitions » Piotroski F-Score

Tilray Brands (Tilray Brands) Piotroski F-Score

: 5 (As of Today)
View and export this data going back to 2015. Start your Free Trial

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Tilray Brands has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Tilray Brands's Piotroski F-Score or its related term are showing as below:

TLRY' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 4   Max: 6
Current: 5

During the past 12 years, the highest Piotroski F-Score of Tilray Brands was 6. The lowest was 1. And the median was 4.


Tilray Brands Piotroski F-Score Historical Data

The historical data trend for Tilray Brands's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tilray Brands Annual Data
Trend Aug14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Piotroski F-Score
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 3.00 3.00 4.00 5.00

Tilray Brands Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Piotroski F-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 5.00 5.00 3.00 5.00

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Tilray Brands's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tilray Brands Piotroski F-Score Distribution

For the Drug Manufacturers industry and Healthcare sector, Tilray Brands's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Tilray Brands's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Feb24) TTM:Last Year (Feb23) TTM:
Net Income was -138.713 + -71.525 + -49.008 + -92.701 = $-351.9 Mil.
Cash Flow from Operations was 43.598 + -15.842 + -30.409 + -15.361 = $-18.0 Mil.
Revenue was 184.188 + 176.949 + 193.771 + 188.34 = $743.2 Mil.
Gross Profit was 67.163 + 44.196 + 47.409 + 49.396 = $208.2 Mil.
Average Total Assets from the begining of this year (Feb23)
to the end of this year (Feb24) was
(4375.9 + 4307.259 + 4402.25 + 4330.557 + 4212.856) / 5 = $4325.7644 Mil.
Total Assets at the begining of this year (Feb23) was $4,375.9 Mil.
Long-Term Debt & Capital Lease Obligation was $365.5 Mil.
Total Current Assets was $631.2 Mil.
Total Current Liabilities was $329.1 Mil.
Net Income was -478.141 + -73.482 + -69.463 + -1170.998 = $-1,792.1 Mil.

Revenue was 153.325 + 153.211 + 144.136 + 145.589 = $596.3 Mil.
Gross Profit was -6.733 + 48.614 + 42.882 + -11.699 = $73.1 Mil.
Average Total Assets from the begining of last year (Feb22)
to the end of last year (Feb23) was
(5819.436 + 5449.694 + 5592.482 + 5474.379 + 4375.9) / 5 = $5342.3782 Mil.
Total Assets at the begining of last year (Feb22) was $5,819.4 Mil.
Long-Term Debt & Capital Lease Obligation was $321.1 Mil.
Total Current Assets was $758.5 Mil.
Total Current Liabilities was $469.7 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Tilray Brands's current Net Income (TTM) was -351.9. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Tilray Brands's current Cash Flow from Operations (TTM) was -18.0. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Feb23)
=-351.947/4375.9
=-0.08042848

ROA (Last Year)=Net Income/Total Assets (Feb22)
=-1792.084/5819.436
=-0.30794806

Tilray Brands's return on assets of this year was -0.08042848. Tilray Brands's return on assets of last year was -0.30794806. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Tilray Brands's current Net Income (TTM) was -351.9. Tilray Brands's current Cash Flow from Operations (TTM) was -18.0. ==> -18.0 > -351.9 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Feb24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Feb23 to Feb24
=365.463/4325.7644
=0.08448518

Gearing (Last Year: Feb23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Feb22 to Feb23
=321.104/5342.3782
=0.06010507

Tilray Brands's gearing of this year was 0.08448518. Tilray Brands's gearing of last year was 0.06010507. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Feb24)=Total Current Assets/Total Current Liabilities
=631.211/329.1
=1.91799149

Current Ratio (Last Year: Feb23)=Total Current Assets/Total Current Liabilities
=758.512/469.682
=1.61494799

Tilray Brands's current ratio of this year was 1.91799149. Tilray Brands's current ratio of last year was 1.61494799. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Tilray Brands's number of shares in issue this year was 754.439. Tilray Brands's number of shares in issue last year was 615.535. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=208.164/743.248
=0.28007341

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=73.064/596.261
=0.12253694

Tilray Brands's gross margin of this year was 0.28007341. Tilray Brands's gross margin of last year was 0.12253694. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Feb23)
=743.248/4375.9
=0.16985032

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Feb22)
=596.261/5819.436
=0.10246027

Tilray Brands's asset turnover of this year was 0.16985032. Tilray Brands's asset turnover of last year was 0.10246027. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+0+1+0+1+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Tilray Brands has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Tilray Brands  (NAS:TLRY) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Tilray Brands Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Tilray Brands's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Tilray Brands (Tilray Brands) Business Description

Address
265 Talbot Street West, Leamington, ON, CAN, N8H 5L4
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products and alcohol.
Executives
Denise M Faltischek officer: Chief Strategy Officer C/O THE HAIN CELESTIAL GROUP, INC., 1111 MARCUS AVENUE, LAKE SUCCESS NY 11042
Mitchell Gendel officer: Global General Counsel EMERALD HOLDING, INC., 100 BROADWAY, 14TH FLOOR, NEW YORK NY 10005
Irwin D Simon director, officer: President & CEO C/O THE HAIN CELESTIAL GROUP INC., 1111 MARCUS AVENUE, LAKE SUCCESS NY 11042
Carl A Merton officer: Chief Financial Officer C/O TILRAY, INC., 745 FIFTH AVENUE, SUITE 1602, NEW YORK NY 10151
Brendan Kennedy director 1920 EASTLAKE AVENUE E., SEATTLE WA 98105
James R. Meiers officer: Head of Canada C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
David G. Hopkinson director C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
Thomas P. Looney director C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
Johann Michael Herhalt director C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
Jodi L. Butts director C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
David F Clanachan director TIM HORTONS INC., 874 SINCLAIR ROAD, OAKVILLE A6 L6K 2Y1
Renah Persofsky director 55 PRINCE ARTHUR AVENUE, #604, TORONTO A6 M5R 1B3
Jon Edward Levin officer: Chief Operating Officer 2701 EASTLAKE AVE E, 3RD FLOOR, SEATTLE WA 98102
Michael C. Kruteck officer: Chief Financial Officer 2701 EASTLAKE AVE E, 3RD FLOOR, SEATTLE WA 98102
Rebekah Dopp director 444 LENOX AVENUE, SOUTH ORANGE NJ 07079